The molecular signature of oncofusion proteins in acute myeloid leukemia

被引:76
作者
Martens, Joost H. A. [1 ]
Stunnenberg, Henk G. [1 ]
机构
[1] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands
关键词
Acute myeloid leukemia; Oncofusion protein; Transcriptional regulation; Epigenetic; ACUTE PROMYELOCYTIC LEUKEMIA; SERUM RESPONSE FACTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; MYOSIN HEAVY-CHAIN; GENE-EXPRESSION; FUSION PROTEIN; TRANSCRIPTION FACTOR; RAR-ALPHA; HISTONE DEACETYLASE; HEMATOPOIETIC-CELLS;
D O I
10.1016/j.febslet.2010.04.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute myeloid leukemia (AML) associated translocations often cause gene fusions that encode onco-fusion proteins. Although many of the breakpoints involved in chromosomal translocations have been cloned, in most cases the role of the chimeric proteins in tumorigenesis is not elucidated. Here we will discuss the fusion proteins of the 4 most common translocations associated with AML as well as the common molecular mechanisms that these four and other fusion proteins utilize to transform progenitor cells. Intriguingly, although the individual partners within the fusion proteins represent a wide variety of cellular functions, at the molecular level many commodities can be found. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2662 / 2669
页数:8
相关论文
共 50 条
  • [21] Molecular signature of retinoic acid treatment in acute promyelocytic leukemia
    Natalia Meani
    Simone Minardi
    Silvia Licciulli
    Vania Gelmetti
    Francesco Lo Coco
    Clara Nervi
    Pier Giuseppe Pelicci
    Heiko Müller
    Myriam Alcalay
    Oncogene, 2005, 24 : 3358 - 3368
  • [22] HDAC Inhibitors in Acute Myeloid Leukemia
    San Jose-Eneriz, Edurne
    Gimenez-Camino, Naroa
    Agirre, Xabier
    Prosper, Felipe
    CANCERS, 2019, 11 (11)
  • [23] Aberrant expression of ecotropic viral integration site-1 in acute myeloid leukemia and acute lymphoblastic leukemia
    Su, Guangsong
    Lian, Xueqi
    Tan, Dongming
    Tao, Huiquan
    Liu, Hong
    Chen, Suning
    Yin, Hongchao
    Wu, Depei
    Yin, Bin
    LEUKEMIA & LYMPHOMA, 2015, 56 (02) : 472 - 479
  • [24] Comparative proteomics in acute myeloid leukemia
    Luczak, Magdalena
    Kazmierczak, Maciej
    Hadschuh, Luiza
    Lewandowski, Krzysztof
    Komarnicki, Mieczyslaw
    Figlerowicz, Marek
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (02): : 95 - 103
  • [25] The genomics of acute myeloid leukemia in children
    Conneely, Shannon E.
    Rau, Rachel E.
    CANCER AND METASTASIS REVIEWS, 2020, 39 (01) : 189 - 209
  • [26] Insights into the New Molecular Updates in Acute Myeloid Leukemia Pathogenesis
    Demir, Derya
    GENES, 2023, 14 (07)
  • [27] Molecular characterization of acute myeloid leukemia and its impact on treatment
    Frankfurt, Olga
    Licht, Jonathan D.
    Tallman, Martin S.
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (06) : 635 - 649
  • [28] Acute Myeloid Leukemia
    Heerema-McKenney, Amy
    Arber, Daniel A.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (04) : 633 - +
  • [29] Acute Myeloid Leukemia
    O'Donnell, Margaret R.
    Abboud, Camille N.
    Altman, Jessica
    Appelbaum, Frederick R.
    Coutre, Steven E.
    Damon, Lloyd E.
    Foran, James M.
    Goorha, Salil
    Maness, Lori J.
    Marcucci, Guido
    Maslak, Peter
    Millenson, Michael M.
    Moore, Joseph O.
    Ravandi, Farhad
    Shami, Paul J.
    Smith, B. Douglas
    Stone, Richard M.
    Strickland, Stephen A.
    Tallman, Martin S.
    Wang, Eunice S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (03): : 280 - 317
  • [30] Acute myeloid leukemia
    Roellig, Christoph
    Thiede, Christian
    Ehninger, Gerhard
    ONKOLOGE, 2017, 23 (07): : 512 - 521